Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Enforcement Report - Week of December 13, 2023
Enforcement Report - Week of November 8, 2023
Padagis` Generic Teriparatide Receives Approval in the U.S.
ALLEGAN, Mich., Oct. 13, 2023 /PRNewswire/ -- Padagis today announced the launch of Brinzolamide Ophthalmic Suspension with Competitive Generic Therapy (CGT) exclusivity (generic equivalent to the Reference Listed Drug Azopt® Ophthalmic Suspension).
Padagis' Generic Halobetasol Propionate Receives Approval in the U.S.
ALLEGAN, Mich., Aug. 8, 2023 /PRNewswire/ -- Padagis LLC, a leading provider of specialty pharmaceuticals, has launched the country's first over-the-counter (OTC) Naloxone HCl Nasal Spray. Naloxone is a medication that is designed to rapidly reverse the effects of opioid overdose. It is a life-saving product that, until now, has only been available as a prescription-labeled drug.
ALLEGAN, Mich., July 19, 2023 /PRNewswire/ -- Padagis, a leading provider of extended topical and other specialty pharmaceuticals, announced today the approval of its over-the-counter (OTC) labeling supplement for naloxone hydrochloride nasal spray (therapeutically equivalent to Narcan® nasal spray).